CORRESPONDENCE (DEPT OF HEALTH)

UPDATED POLICY FOR MANAGEMENT OF SELF-ISOLATION OF CLOSE CONTACTS OF COVID 19 CASES - ADDITIONAL SAFEGUARDS FOR HEALTH AND SOCIAL CARE STAFF  -   Annex A  -  30st December 2021

JCVI UPDATE ON ADVICE FOR COVID-19 VACCINATION OF CHILDREN AND YOUNG PEOPLE  24th December 2021

ADDENDUM No 2   nMABs in the treatment of COVID-19 in hospitalised patients  December 2021

UPDATED POLICY FOR MANAGEMENT OF SELF-ISOLATION OF CLOSE CONTACTS OF COVID 19 CASES - ADDITIONAL SAFEGUARDS FOR HEALTH AND SOCIAL CARE STAFF   -  21st December 2021

SUSPENSION OF THE 15 MINUTE WITH MRNA VACCINE FOR COVID 19  15th Dec 2021

COVID-19 THERAPEUTIC ALERT – WITHDRAWAL OF THE RECOMMENDATION FOR CONSIDERATION OF INHALED BUDESONIDE AS A TREATMENT OPTION FOR COVID-19  14th Dec 2021

IMMEDIATE ACTIONS IN RESPONSE TO NEW VARIANT SARS-COV-2 IDENTIFIED 26.11.21

PATIENTS REQUIRING ASTRAZENECA VACCINE AS A BOOSTER  15th Nov 2021

VACCINE SUPPLY FOR THE COVID-19 BOOSTER VACCINATION PROGRAMME  7th Oct 2021

Letter to Community Pharmacy Contractors re CP self isolation   5th October 2021

COVID-19 BOOSTER VACCINE PROGRAMME FOR WINTER 2021/22  24th Sept 2021

DEPLOYMENT OF THE PFIZER AND MODERNA COVID-19 VACCINES IN GENERAL PRACTICE  23rd Sept 2021

THE USE OF UNLICENSED MEDICINES IN THE TREATMENT OF COVID-19  23rd Sept 2021

COVID-19 THERAPEUTIC ALERT: CASIRIVIMAB AND IMDEVIMAB (RONAPREVE®) FOR PATIENTS HOSPITALISED DUE TO COVID-19  20th September 2021

Ronapreve Hospitalised Patients  20th September 2021

Advice On Third Primary Dose For COVID-19 Vaccination  20th Sept 2021

Updated Policy For Management of Self-Isolation of Close Contacts of COVID-19 Cases Who Are Fully Vaccinated  24th August 2021

Updated JCVI Advice re: Children 12-17 Years of Age  3rd August 2021

Change of Dose Intervals Between Pfizer-Biontech & Moderna COVID-19 Vaccines  30th July 2021

Remdesivir for Patients Hospitalised with COVID-19  15th June 2021

Remdesivir May 2021 Updated Policy  15th June 2021

Change of Dose Interval Between COVID-19 Vaccines  10th June 2021

Letter - Vaccination Protocol for COVID-19 Vaccine Moderna  8th June 2021

COVID-19 Vaccination Protocol for Moderna Vaccine  8th June 2021

Updated Vaccination Protocol for COVID-19 AstraZeneca Vaccine  26th May 2021

Use of the AstraZeneca Vaccine : Advice on Updated JCVI Statement  7th May 2021

MHRA and JCVI Announcement - AZ Vaccine Updated Contraindications  29.04.21

JCVI Announcement Regarding COVID-19 Vaccination During Pregnancy 27.04.21

Vaccination Protocol for COVID-19 Vaccine (Pfizer) and (AstraZeneca)  27.04.2021

COVID-19 Vaccination Protocol for Pfizer Vaccine (version 1.0a)  28.04.2021

COVID-19 Vaccination Protocol for AstraZeneca Vaccine (version 1.1)  27.04.2021

COVID-19 Therapeutic Alert - Inhaled Budesonide for Adults (50 and over) with COVID-19  13th March 2021

COVID-19 VACCINE ASTRAZENECA AND THROMBOEMBOLIC EVENTS WITH CONCURRENT LOW PLATELET COUNTS   8th April 2021

PALIVIZUMAB PASSIVE IMMUNISATION AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN AT-RISK PRE-TERM INFANTS  31st March 2021

Vaccination Protocol for COVID-19 Vaccine AstraZeneca Letter plus Protocol

Convalscent Plasma in the Management of Hospitilised Patients with COVID-19  19th March 2021

COVID-19 Vaccines - Weekly Publication of Yellow Card Safety Data  19th Feb 2021

COVID-19 THERAPEUTIC ALERT – COLCHICINE IN THE MANAGEMENT OF COVID-19 POSITIVE PATIENTS – USE ONLY IN A CLINICAL TRIAL SETTING - 15th February 2021

New Inspection Model 2021  12th February 2021

COVID-19 THERAPEUTIC ALERT - INTERLEUKIN-6 INHIBITORS (TOCILIZUMAB OR SARILUMAB) FOR CRITICALLY ILL PATIENTS WITH COVID-19 PNEUMONIA (ADULTS) – UPDATE 2nd Feb 2021

COVID-19 Therapeutic Alert - Antimicrobials (Azithromycin and Doxycycline) Not Beneficial in the Management of COVID-19 (SARS-COV-2)  29th January 2021

Updated Guidance on Timing of COVID-19 Vaccine Interval in Patients Due to Recieve Treatment with Immunosuppressants  28th January 2021

Prescribing of Vitamin D as a Preventative Measure Against COVID-19  22.01.21

Guidance - COVID-19 Vaccine AstraZeneca to Vaccinate Housebound 21.01.21

New Variants of SARS-COV-2 Virus (Brazilian Variants) - Action for HSC  18.01.21

Support Doctors throughout COVID-19 Pandemic plus CMOs Letter  12th Jan 2021

COVID-19 Therapeutic Alert - Interleukin-6 Inhibitors for Patients Admitted to Critical Care Settings with COVID-19 Pneumonia (Adults12th January 2021

Data Capture from the COVID-19 Vaccination Programme  11th January 2021

Timing of Interval Between COVID-19 Vaccine Doses  8th January 2021

Vaccination of Community Pharmacy Staff   7th January 2021 

Deployment of COVID-19 Vaccine - Oxford/AstraZeneca Governance, Handling and Preparation in General Practice  5th January 2021 

Letter to the Profession from UK CMOs regarding COVID-19 Vacc programme 31st December 2020

Short Statement - First Dose Prioritisation  31st December 2020

CEM CMO 2020 Greenbook (1)  31st December 2020

New Variant of SARS-COV-2 Virus in South Africa - Action for HSC  Update 04/01/21

Deployment of the AstraZeneca COVID-19 Vaccine in NI  30th December 2020

New Variant of SARS-COV-2 Virus in South Africa - Action for HSC  24th Dec 2020

COVID-19 THERAPEUTIC ALERT - THERAPEUTIC ANTICOAGULATION (HEPARIN) IN THE MANAGEMENT OF SEVERE COVID-19 POSITIVE PATIENTS  23rd Dec 2020

DOH Correspondence regarding Essential Services  23rd December 2020

The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020  21 Dec 2020

Updated Resuscitation Council UK Guidance on The Management of Anaphylaxis in the Vaccination Setting  18th December 2020

COVID-19 Therapeutic Alert - Azithromycin in the Management of COVID-19 Positive Patients  16th December 2020

Pfizer Biontech Covid-19 Vaccine - Updated Guidance on Managing Allergic Reactions 10th December 2020

Expression of Interest - Reg Health Care Professionals - Sessional Vaccinators for COVID-19 Vaccination Programme  17th November 2020

Early Alert System - Updated Circular plus Annex C (follow up proforma)  13th Nov 2020

IMMEDIATE ACTIONS IN RESPONSE TO MINK-VARIANT SARS-COV-2 VIRUS IN DENMARK  9th November 2020

THE HUMAN MEDICINES (CORONAVIRUS AND INFLUENZA) (AMENDMENT) REGULATIONS 2020: AMENDMENTS TO THE HUMAN MEDICINES REGULATIONS 2012  27th October 2020

Shielding Guidance for Children and Young People (RCPCH)  6th October 2020

Minimising Risks of COVID-19 Outbreaks in Healthcare Settings  17th Sept 2020

Letter from Cathy Harrison-Protecting Community Pharmacy Teams  10th Sept 2020

COVID-19 Clinical Staff Alert plus COVID-19 Research Letter 18th Aug 2020

Use of Face Masks in all Health and Social Care Facilities  11th August 2020

Personal Protective Equipment - Risk of Heat Stress  30th July 2020

Community Pharmacy Commissioning Plan 2020/21  1st July 2020

Letter from CMO - Dexamethasone in COVID-19  16th June 2020

Dexamethasone in COVID-19 - Letter from CMO's  16th June 2020

Cardiopulmonary Resuscitation (CPR) as an Aerosol Generating Procedure 13th June 2020

Regional Ethics Advice and Support Framework  10th June 2020

COVID-19 Guidance : Ethical Advice and Support Framework  10th June 2020

SARS - CoV2 Antibody Testing - Programme Rollout  9th June 2020

COVID-19 Contact Tracing Strategy and Programme  29th May 2020

Letter from CMO plus General Case Definition for the Public

Tiger Eye Protector Product - Removal From Supply Chain in Respect of COVID-19 Use

Letter from Cathy Harrison CPO - Pharmacy Pre-Registration Placements

Letter from Dr McBride - Recruiting Patients for Clinical Trials for COVID-19 Therapeutics plus CMOs Letter

Clarity on Prescribing Rights for Health and Care Professions Council (HCPC)

Yellow Card Reporting Site for Healthcare Products Used in Coronaviras COVID-19

Valproate Pregnancy Prevention Programme : Temporary Advice for Management During COVID-19

Multisystem Inflammatory Syndrome in Children Temporarily Associated with COVID-19

COVID-19 - PPE Guidance Update 19th April 2020

Continuation of Immunisation Programmes During COVID-19 Pandemic

Message to All Clinical Staff - Ibuprofen and Coronavirus (COVID-19)

COVID-19 PPE Guidance Update 3rd April 2020

COVID-19 - Easy Visual Guide to PPE - Poster

Additional Considerations of COVID-19 - Poster

Recommended PPE for Primary, Outpatient and Community Care by Setting, NHS and Independent Sector

T3 Recommended PPE for Ambulance Staff, Paramedics, First Responders and Pharmacists - Poster

COVID-19 - Optimising Use of Critical Care Medicines

Letter to Pharmacy Contractors from Cathy Harrison Chief Pharmaceutical Officer - 1st April 2020

Personal Protective Equipment (PPE) - Update to Service 30th March 2020

Chloroquine and Hydroxychloroquine Not Licensed for COVID-19 Treatment

Novel Coronavirus - Anti-inflammatory medications

Advice for HSC in Northern Ireland

COVID-19 Maintaining the Supply of Medicines to Patients